You have 9 free searches left this month | for more free features.

Fatty Liver

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cushing Syndrome, Fatty Liver Disease Trial (hepatic MRI)

Not yet recruiting
  • Cushing Syndrome
  • Fatty Liver Disease
  • hepatic MRI
  • (no location specified)
May 25, 2023

Obesity Trial in Kuala Lumpur (Tocotrienol-rich fraction vitamin E (TRF), Placebo)

Completed
  • Obesity
  • Tocotrienol-rich fraction vitamin E (TRF)
  • Placebo
  • Kuala Lumpur, Malaysia
    National University Of Malaysia
Jun 7, 2023

Non-alcoholic Fatty Liver Disease in Chronic Kidney Disease in

Not yet recruiting
  • CKD
  • NAFLD
    • (no location specified)
    Aug 22, 2023

    Betweenq MAFLD and Chronic Kidney Disease

    Not yet recruiting
    • Mafld in Ckd Patients
      • (no location specified)
      Nov 12, 2023

      Fatty Liver Trial (Non-contrast low-dose abdomen CT, Fibroscan, bioelectrical impedance analysis (BIA))

      Not yet recruiting
      • Fatty Liver
      • Non-contrast low-dose abdomen CT
      • +2 more
      • (no location specified)
      Jan 14, 2023

      Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease

      Enrolling by invitation
      • Non-Alcoholic Fatty Liver Disease
        • Castellana Grotte, Bari, Italy
          Irccs Saverio de Bellis
        Sep 6, 2023

        Novel Antidiabetic Medications and Their Effect on Liver

        Completed
        • Non-Alcoholic Fatty Liver Disease
        • Liver Steatosis
        • Athens, Attiki, Greece
          "Hippocration" General Hospital of Athens
        Jul 13, 2023

        Heart Failure With Preserved Ejection Fraction, Non Alcoholic Fatty Liver Trial in Sohag (echocardiography)

        Not yet recruiting
        • Heart Failure With Preserved Ejection Fraction
        • Non Alcoholic Fatty Liver
        • echocardiography
        • Sohag, El Monshah, Egypt
        • +1 more
        Apr 7, 2023

        NAFLD Trial in Cairo (Lubiprostone 24Mcg Oral Cap)

        Recruiting
        • NAFLD
        • Lubiprostone 24Mcg Oral Cap
        • Cairo, Egypt
          National Hepatology and Tropical Medicine Research Institute
        Mar 2, 2023

        Non-Alcoholic Fatty Liver Disease Trial in Shanghai (2D ultrasound scan and MRI examination)

        Recruiting
        • Non-Alcoholic Fatty Liver Disease
        • 2D ultrasound scan and MRI examination
        • Shanghai, China
          Xinhua Hospital affiliated to Shanghai Jiao Tong University Scho
        Oct 18, 2023

        hsCAR and MAFLD: A Cross-sectional Study

        Recruiting
        • Metabolic Dysfunction-associated Fatty Liver Disease
        • +2 more
        • high-sensitivity C-reactive protein to albumin ratio
        • Chongqing, Chongqing, China
          The Second Affiliated Hospital of Chongqing Medical University
        Aug 2, 2023

        NAFLD, Non-alcoholic Fatty Liver Disease Trial in Sulaymaniyah (Beetroot juice, , Mediterranean diet alone (MeD))

        Completed
        • NAFLD, Non-alcoholic Fatty Liver Disease
        • Beetroot juice
        • +3 more
        • Sulaymaniyah, Sulaimanyah, Iraq
          Hawal
        Jun 8, 2023

        Non-alcoholic Fatty Liver Disease in Polycystic Ovary Syndrome

        Completed
        • PCOS
        • NAFLD
        • Questionnaire
        • Ankara, Turkey
          Hacettepe University Nutrition and Dietetics Department
        Apr 25, 2023

        Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma Trial in Roma (Handgrip strength test, total body

        Recruiting
        • Liver Cirrhosis
        • +2 more
        • Handgrip strength test
        • +2 more
        • Roma, RM, Italy
          CEMAD
        Oct 20, 2023

        Non-alcoholic Fatty Liver Disease, Obesity Trial (BI 3006337, Placebo matching BI 3006337)

        Not yet recruiting
        • Non-alcoholic Fatty Liver Disease
        • Obesity
        • BI 3006337
        • Placebo matching BI 3006337
        • (no location specified)
        Jul 25, 2023

        Fatty Liver Disease Trial (Empagliflozin 10 MG)

        Not yet recruiting
        • Fatty Liver Disease
        • Empagliflozin 10 MG
        • (no location specified)
        Jan 19, 2023

        Non-Alcoholic Fatty Liver Disease Trial in Bandirma (In the study, biochemical parameters will be taken from the anthropometric

        Completed
        • Non-Alcoholic Fatty Liver Disease
        • In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.
        • Bandırma, Balıkesir, Turkey
          Bandırma onyedi eylül unıversıty
        Apr 11, 2023

        Steatohepatitis, Nonalcoholic, Steatosis, Liver Diseases Trial in Curitiba (NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER

        Active, not recruiting
        • Steatohepatitis, Nonalcoholic
        • +3 more
        • NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER DISEASE NON-ALCOHOLIC (NAFLD).
        • Curitiba, Parana, Brazil
          Hospital de Clínicas da Universidade Federal do Paraná
        Jul 17, 2023

        NAFLD Trial (Caloric restriction intervention, No intervention)

        Not yet recruiting
        • NAFLD
        • Caloric restriction intervention
        • No intervention
        • (no location specified)
        Apr 24, 2023

        Non-Alcoholic Fatty Liver Disease, Obesity Trial in Hong Kong (Once-a-week Exercise, Thrice-a-week Exercise, Usual Care Control)

        Not yet recruiting
        • Non-Alcoholic Fatty Liver Disease
        • Obesity
        • Once-a-week Exercise
        • +2 more
        • Hong Kong, Hong Kong
          LKS Faculty of Medicine
        Feb 23, 2023

        SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

        Not yet recruiting
        • Metabolic Associated Fatty Liver Disease
        • Recombinant protein vaccine and adenovirus vector vaccine
        • (no location specified)
        Feb 12, 2023

        Metabolic Associated Fatty Liver Disease and Biopsy Proved Cases

        Recruiting
        • Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development
          • Asyut, Egypt
          • +1 more
          Nov 27, 2023

          Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial in San Antonio (AZD7503 Intervention)

          Active, not recruiting
          • Non-alcoholic Fatty Liver Disease
          • +5 more
          • AZD7503 Intervention
          • San Antonio, Texas
            Research Site
          Jan 13, 2023

          Non-Alcoholic Fatty Liver Disease Trial in Hong Kong (Ambulatory monitoring of liver fat, Standard of care)

          Not yet recruiting
          • Non-Alcoholic Fatty Liver Disease
          • Ambulatory monitoring of liver fat
          • Standard of care
          • Hong Kong, Select A State Or Province, China
            The University of Hong Kong
          Mar 1, 2023

          Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease Trial in Taipei (exercise)

          Enrolling by invitation
          • Chronic Hepatitis B
          • Non-alcoholic Fatty Liver Disease
          • exercise
          • Taipei, Zhongzheng Dist., Taiwan
            National Taiwan University Hospital
          Jul 13, 2023